🇺🇸 FDA
Patent

US 6018102

Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same

expired A61KA61K38/10A61K38/17

Quick answer

US patent 6018102 (Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same) held by THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE
Grant date
Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/10, A61K38/17, A61K38/1703, A61K38/1709